Works matching IS 02704137 AND DT 2014 AND VI 74 AND IP 8

Results: 10

The 20th Annual Prostate Cancer Foundation Scientific Retreat report.

Published in:

Prostate, 2014, v. 74, n. 8, p. 811, doi. 10.1002/pros.22808

By:

Miyahira, Andrea K.;
Simons, Jonathan W.;
Soule, Howard R.

Publication type:

Article

Androgen withdrawal fails to induce detectable tissue hypoxia in the rat prostate.

Published in:

Prostate, 2014, v. 74, n. 8, p. 805, doi. 10.1002/pros.22803

By:

Regter, Sietze;
Hedayati, Mohammad;
Zhang, Yonggang;
Zhou, Haoming;
Dalrymple, Susan;
Koch, Cameron J.;
Isaacs, John T.;
DeWeese, Theodore L.

Publication type:

Article

Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia.

Published in:

Prostate, 2014, v. 74, n. 8, p. 892, doi. 10.1002/pros.22807

By:

O'Malley, Katherine J.;
Eisermann, Kurtis;
Pascal, Laura E.;
Parwani, Anil V.;
Majima, Tsuyoshi;
Graham, Lara;
Hrebinko, Katherine;
Acquafondata, Marie;
Stewart, Nicolas A.;
Nelson, Joel B.;
Yoshimura, Naoki;
Wang, Zhou

Publication type:

Article

Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival.

Published in:

Prostate, 2014, v. 74, n. 8, p. 820, doi. 10.1002/pros.22788

By:

Sharma, Jaya;
Gray, Kathryn P.;
Harshman, Lauren C.;
Evan, Carolyn;
Nakabayashi, Mari;
Fichorova, Raina;
Rider, Jennifer;
Mucci, Lorelei;
Kantoff, Philip W.;
Sweeney, Christopher J.

Publication type:

Article

Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer.

Published in:

Prostate, 2014, v. 74, n. 8, p. 829, doi. 10.1002/pros.22799

By:

Shiota, Masaki;
Itsumi, Momoe;
Yokomizo, Akira;
Takeuchi, Ario;
Imada, Kenjiro;
Kashiwagi, Eiji;
Inokuchi, Junichi;
Tatsugami, Katsunori;
Uchiumi, Takeshi;
Naito, Seiji

Publication type:

Article

Clinical presentation of prostate cancer in Black South Africans.

Published in:

Prostate, 2014, v. 74, n. 8, p. 880, doi. 10.1002/pros.22806

By:

Tindall, Elizabeth A.;
Monare, L. Richard;
Petersen, Desiree C.;
van Zyl, Smit;
Hardie, Rae‐Anne;
Segone, Alpheus M.;
Venter, Philip A.;
Bornman, M.S. Riana;
Hayes, Vanessa M.

Publication type:

Article

Inhibition of CYP17A1 activity by resveratrol, piceatannol, and synthetic resveratrol analogs.

Published in:

Prostate, 2014, v. 74, n. 8, p. 839, doi. 10.1002/pros.22801

By:

Oskarsson, Agneta;
Spatafora, Carmela;
Tringali, Corrado;
Andersson, Åsa Ohlsson

Publication type:

Article

Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment.

Published in:

Prostate, 2014, v. 74, n. 8, p. 869, doi. 10.1002/pros.22805

By:

Zhang, Qiuyang;
Liu, Sen;
Zhang, Qingsong;
Xiong, Zhenggang;
Wang, Alun R.;
Myers, Leann;
Melamed, Jonathan;
Tang, Wendell W.;
You, Zongbing

Publication type:

Article

NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: Involvement in cancer progressiveness.

Published in:

Prostate, 2014, v. 74, n. 8, p. 901, doi. 10.1002/pros.22809

By:

Morimoto, Kazuya;
Tanaka, Tomoaki;
Nitta, Yujiro;
Ohnishi, Keiko;
Kawashima, Hidenori;
Nakatani, Tatsuya

Publication type:

Article

Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.

Published in:

Prostate, 2014, v. 74, n. 8, p. 852, doi. 10.1002/pros.22804

By:

Gravina, Giovanni Luca;
Marampon, Francesco;
Sherris, David;
Vittorini, Francesca;
Cesare, Ernesto Di;
Tombolini, Vincenzo;
Lenzi, Andrea;
Jannini, Emmanuele A.;
Festuccia, Claudio

Publication type:

Article